EMT is an important process that determines the fate of tumor cells and influences their malignant metastasis, and miRNAs regulate the EMT process by affecting the expression of related proteins in the PI3K/AKT signaling pathway, suggesting that blocking lung cancer cell metastasis by regulating the expression of these miRNAs may be a new therapeutic idea. This evidence concerns the gene AKT1 and lung carcinoma.